Safety in patients with existing mild-moderate liver disease Correlation between weight loss and estimated liver fat reduction TRIUMPH-2 (Ongoing, Expected 2026) Primary Endpoints: Weight loss in diabetic patients HbA1c reduction Secondary Endpoints (Liver): Liver enzymes Metabolic markers Diabetic Population Note: Higher prevalence of MASLD/NASH (~40-50%), so liver benefits particularly important in this group
Taking these supplements together, either as separate products or in combination formulas, can provide complementary protection for liver cells whilst supporting multiple aspects of liver health simultaneously
IGF-1 (Insulin-like growth factor) is an endocrine hormone that is produced in the liver
You pay one monthly fee that covers the clinician consultations, the medication itself, all supplies, and ongoing support
$79/first month Applies to 3-month plan billed in full ($149/mo after) Whats included Personalized, clinician-guided plan Monthly and 3-month plans Dispensed by US-licensed compounding pharmacy Unlimited protocol adjustments and messaging Ongoing support and check-ins Pause or cancel anytime Backed by our in-house Stanford PhD-led team Get Started Made for your biology No two people age the same way, so no two treatments are exactly the same